Bexmarilimab
Bexmarilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Bexmarilimab is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).
| Trade Name | Bexmarilimab |
| Generic | Bexmarilimab |
| Bexmarilimab Other Names | Anti-clever-1 monoclonal antibody FP-1305, Bexmarilimab, Clevegen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bexmarilimab
